Literature DB >> 24210250

Early MRI in term infants with perinatal hypoxic-ischaemic brain injury: interobserver agreement and MRI predictors of outcome at 2 years.

S K Goergen1, H Ang2, F Wong3, E A Carse4, M Charlton5, R Evans6, G Whiteley6, J Clark6, D Shipp6, D Jolley7, E Paul7, J L Y Cheong8.   

Abstract

AIM: To compare diffusion-weighted imaging (DWI) and non-DWI magnetic resonance imaging (MRI), proton MR spectroscopy (1H-MRS), and clinical biomarkers for prediction of 2 year developmental outcome in term infants with perinatal hypoxic-ischaemic encephalopathy (HIE).
MATERIALS AND METHODS: Nineteen infants ≥36 weeks gestation with HIE were recruited and MRI performed day 3-7 (mean = 5). MRI was scored independently by three radiologists using a standardized scoring system. Lactate-to-N-acetylaspartate ratio (Lac:NAA) in the lentiform nucleus was calculated. Developmental assessment was performed at 2 years using the Bayley Scales of Infant and Toddler Development (BSID-III). Interobserver agreement about abnormality in 10 brain regions was measured. Univariate analysis was performed to determine variables associated with adverse outcome (i.e., death or Bayley score for any domain <70).
RESULTS: Good interobserver agreement (kappa = 0.61-0.69) on scores for DWI was obtained for the cortex, putamen, and brainstem, but not for any region on non-DWI. A significant association was found between outcome and Lac:NAA (p < 0.003) and DWI scores for lentiform nucleus, thalamus, cortex, posterior limb of the internal capsule (PLIC), and paracentral white matter (p = 0.001-0.013), but for non-DWI score only in the vermis or brainstem. A combination of Lac:NAA ≥0.25 or DWI/apparent diffusion coefficient (ADC) signal abnormality in the PLIC had 100% specificity and sensitivity for poor outcome.
CONCLUSION: Interobserver agreement for non-DWI performed during the first week is poor. Agreement by three radiologists about the presence of abnormal signal within the PLIC on ADC/DWI images or elevation of Lac:NAA above 0.25 improved sensitivity without reducing the prognostic specificity of MRS in the 19 patients, but this requires validation in a larger group of infants with HIE who have been treated with hypothermia.
Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24210250     DOI: 10.1016/j.crad.2013.09.001

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  17 in total

1.  Voxelwise and Regional Brain Apparent Diffusion Coefficient Changes on MRI from Birth to 6 Years of Age.

Authors:  Susan Sotardi; Randy L Gollub; Sara V Bates; Rebecca Weiss; Shawn N Murphy; P Ellen Grant; Yangming Ou
Journal:  Radiology       Date:  2020-12-08       Impact factor: 11.105

2.  Optimizing Cerebral Autoregulation May Decrease Neonatal Regional Hypoxic-Ischemic Brain Injury.

Authors:  Jennifer K Lee; Andrea Poretti; Jamie Perin; Thierry A G M Huisman; Charlamaine Parkinson; Raul Chavez-Valdez; Matthew O'Connor; Michael Reyes; Jillian Armstrong; Jacky M Jennings; Maureen M Gilmore; Raymond C Koehler; Frances J Northington; Aylin Tekes
Journal:  Dev Neurosci       Date:  2016-12-16       Impact factor: 2.984

Review 3.  Metabolic Alterations in Developing Brain After Injury: Knowns and Unknowns.

Authors:  Mary C McKenna; Susanna Scafidi; Courtney L Robertson
Journal:  Neurochem Res       Date:  2015-07-07       Impact factor: 3.996

4.  Using clinically acquired MRI to construct age-specific ADC atlases: Quantifying spatiotemporal ADC changes from birth to 6-year old.

Authors:  Yangming Ou; Lilla Zöllei; Kallirroi Retzepi; Victor Castro; Sara V Bates; Steve Pieper; Katherine P Andriole; Shawn N Murphy; Randy L Gollub; Patricia Ellen Grant
Journal:  Hum Brain Mapp       Date:  2017-03-31       Impact factor: 5.038

Review 5.  Lactylation may be a Novel Posttranslational Modification in Inflammation in Neonatal Hypoxic-Ischemic Encephalopathy.

Authors:  Yue Zhou; Li Yang; Xiaoying Liu; Hao Wang
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

6.  Neonatal brain microstructure correlates of neurodevelopment and gait in preterm children 18-22 mo of age: an MRI and DTI study.

Authors:  Jessica Rose; Katelyn Cahill-Rowley; Rachel Vassar; Kristen W Yeom; Ximena Stecher; David K Stevenson; Susan R Hintz; Naama Barnea-Goraly
Journal:  Pediatr Res       Date:  2015-08-31       Impact factor: 3.756

7.  Limitations of Conventional Magnetic Resonance Imaging as a Predictor of Death or Disability Following Neonatal Hypoxic-Ischemic Encephalopathy in the Late Hypothermia Trial.

Authors:  Abbot R Laptook; Seetha Shankaran; Patrick Barnes; Nancy Rollins; Barbara T Do; Nehal A Parikh; Shannon Hamrick; Susan R Hintz; Jon E Tyson; Edward F Bell; Namasivayam Ambalavanan; Ronald N Goldberg; Athina Pappas; Carolyn Huitema; Claudia Pedroza; Aasma S Chaudhary; Angelita M Hensman; Abhik Das; Myra Wyckoff; Amir Khan; Michelle C Walsh; Kristi L Watterberg; Roger Faix; William Truog; Ronnie Guillet; Gregory M Sokol; Brenda B Poindexter; Rosemary D Higgins
Journal:  J Pediatr       Date:  2020-11-13       Impact factor: 4.406

8.  Interobserver Reliability of an MR Imaging Scoring System in Infants with Hypoxic-Ischemic Encephalopathy.

Authors:  E Szakmar; H Meunier; M El-Dib; E Yang; T E Inder
Journal:  AJNR Am J Neuroradiol       Date:  2021-03-25       Impact factor: 3.825

9.  MRI Score Ability to Detect Abnormalities in Mild Hypoxic-Ischemic Encephalopathy.

Authors:  Michelle Machie; Lauren Weeke; Linda S de Vries; Nancy Rollins; Larry Brown; Lina Chalak
Journal:  Pediatr Neurol       Date:  2020-11-28       Impact factor: 3.372

10.  Evolution of Apparent Diffusion Coefficient and Fractional Anisotropy in the Cerebrum of Asphyxiated Newborns Treated with Hypothermia over the First Month of Life.

Authors:  Saskia Kwan; Elodie Boudes; Anouk Benseler; Guillaume Gilbert; Christine Saint-Martin; Michael Shevell; Pia Wintermark
Journal:  Neural Plast       Date:  2015-07-02       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.